Bone News and Research

RSS

Analysis finds more than 100 new genetic risk factors strongly linked to colorectal cancer

A comprehensive analysis of more than 100,000 colorectal cancer (CRC) cases, led by researchers at the Fred Hutchinson Cancer Center in Seattle and 200 scientific collaborators worldwide, has identified more than 100 new genetic risk factors strongly linked with the disease.

20 Dec 2022

Study shows positive effect of concentrating surgery for children with neuroblastoma

Neuroblastoma is a tumor of the sympathetic nervous system that occurs mainly in young children. Every year, 25 children in the Netherlands receive this diagnosis. Surgery to remove the tumor tissue forms an important part of the treatment plan.

19 Dec 2022

AI-based image analysis software for diagnosis of hip dysplasia can save time, costs

The deployment of an artificial intelligence (AI) based image analysis software for the diagnosis of hip dysplasia can save time and costs without compromising the reliability of the diagnosis.

18 Dec 2022

Developing stem cell sheet for enhancement of angiogenesis which promotes cardiac repair

Myocardial infarction is an ischemic disease in which a coronary artery supplying blood to the heart muscle is stenotic or obstructed, resulting in cardiac tissue necrosis.

16 Dec 2022

Study to determine if a DNA-based blood test can help detect cancer predisposition in NF1 patients

The Children’s Tumor Foundation (CTF) has announced a groundbreaking 3-year study, which it will fund for nearly $2 million, to determine if a DNA-based blood test can offer better understanding and ultimately earlier diagnosis of cancer predisposition in neurofibromatosis type 1 (NF1) patients.

16 Dec 2022

Adding Gli1+ cells could regenerate the enthesis after rotator cuff surgery

In the annals of shoulder surgery, NFL quarterback Drew Brees is an anomaly. In 2005, Brees was tackled and the rotator cuff tendon in his throwing shoulder was severely torn, a potentially career-ending injury.

16 Dec 2022

Is bottled water really safer?

A new study looked at over 500 contaminants and indicators of microbial activity in 30 brands of bottled water and found some evidence that this supposition might be unfounded.

16 Dec 2022

Imaging method yields highly accurate and precise values of radionuclide organ uptake

Patients with cancer that has spread to the bone are sometimes treated with alpha particle radiation therapy that is delivered into or very close to the tumor.

16 Dec 2022

Study uncovers new immune target to treat atherosclerosis

For the longest time, clinicians have treated cardiovascular disease by focusing on diabetes and blood pressure control, reducing cholesterol using medications like aspirin and statins.

16 Dec 2022

Intermittent fasting diet intervention may help patients to achieve complete diabetes remission

After an intermittent fasting diet intervention, patients achieved complete diabetes remission, defined as an HbA1c (average blood sugar) level of less than 6.5% at least one year after stopping diabetes medication, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

15 Dec 2022

Novel experimental system traces the development and longevity of plasma cells

Just as a fire department mobilizes in response to a reported fire, specialized immune cells in the body mobilize in response to the introduction of foreign substances known as antigens.

15 Dec 2022

Vitamin D levels for population in the Mediterranean area are not sufficiently analyzed, researchers say

Vitamin D is a hormone that is essential to a number of bodily processes, mainly absorbing and maintaining calcium, which is key for strong bones, but it also plays a role in inflammation processes, the immune system, cell growth and the metabolism.

14 Dec 2022

Major treatment advance revealed for adults with newly diagnosed B lineage acute lymphoblastic leukemia

Late-breaking research reveals a major treatment advance for adults with newly diagnosed B lineage acute lymphoblastic leukemia (ALL).

14 Dec 2022

People with daily step count of 10,700 are 44% less likely to develop type 2 diabetes

Wearable fitness devices offer new insights into the relationship between physical activity and type 2 diabetes, according to a new analysis of the National Institutes of Health's All of Us Research Program data published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

13 Dec 2022

Vitamin D supplements reduce the risk of dynapenia in older people by 78%

Vitamin D plays an important role in the regulation of calcium and phosphorus absorption by the organism.

13 Dec 2022

Targeted therapies and novel drug combinations show promise for the treatment of multiple leukemias

Researchers from The University of Texas MD Anderson Cancer Center are presenting compelling findings from three clinical trials at the 2022 American Society of Hematology Annual Meeting.

13 Dec 2022

Researchers develop new porous material capable of regenerating bones and preventing infections

Researchers from the Bioengineering and Biomaterials Laboratory of Universidad Católica de Valencia (UCV) have developed a new porous material capable of regenerating bones and preventing infections at the same time.

12 Dec 2022

Novel drug shows early potential in combating multiple myeloma

A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow cancer, in a study presented by researchers from the University of Pennsylvania's Abramson Cancer Center at the 2022 American Society of Hematology Annual Meeting (Abstract 565).

12 Dec 2022

Many genetic disorders respond well to specialized gene therapy

When the normal DNA sequence in an individual changes or mutates it can cause disease. The mutation may involve multiple genes and may be caused by environmental factors, or there may be chromosomal defects that are harmful at birth, in infancy or environment at a later stage.

12 Dec 2022

GOSH delivers world-first base-edited cell therapy for a patient with relapsed T cell leukemia

A patient with relapsed T cell leukemia has been given base-edited T-cells in a world-first use of a base-edited cell therapy, in a 'bench-to-bedside' collaboration between UCL and Great Ormond Street Hospital for Children (GOSH).

12 Dec 2022

Bone News and Research

Analysis finds more than 100 new genetic risk factors strongly linked to colorectal cancer

Study shows positive effect of concentrating surgery for children with neuroblastoma

AI-based image analysis software for diagnosis of hip dysplasia can save time, costs

Developing stem cell sheet for enhancement of angiogenesis which promotes cardiac repair

Study to determine if a DNA-based blood test can help detect cancer predisposition in NF1 patients

Adding Gli1+ cells could regenerate the enthesis after rotator cuff surgery

Is bottled water really safer?

Imaging method yields highly accurate and precise values of radionuclide organ uptake

Study uncovers new immune target to treat atherosclerosis

Intermittent fasting diet intervention may help patients to achieve complete diabetes remission

Novel experimental system traces the development and longevity of plasma cells

Vitamin D levels for population in the Mediterranean area are not sufficiently analyzed, researchers say

Major treatment advance revealed for adults with newly diagnosed B lineage acute lymphoblastic leukemia

People with daily step count of 10,700 are 44% less likely to develop type 2 diabetes

Vitamin D supplements reduce the risk of dynapenia in older people by 78%

Targeted therapies and novel drug combinations show promise for the treatment of multiple leukemias

Researchers develop new porous material capable of regenerating bones and preventing infections

Novel drug shows early potential in combating multiple myeloma

Many genetic disorders respond well to specialized gene therapy

GOSH delivers world-first base-edited cell therapy for a patient with relapsed T cell leukemia

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News